| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ADMA | Common Stock | Options Exercise | $435,031 | +118,861 | +25% | $3.66 | 586,166 | 29 Aug 2024 | Direct | |
| transaction | ADMA | Common Stock | Options Exercise | $53,640 | +9,000 | +1.5% | $5.96 | 595,166 | 29 Aug 2024 | Direct | |
| transaction | ADMA | Common Stock | Options Exercise | $97,200 | +9,000 | +1.5% | $10.80 | 604,166 | 29 Aug 2024 | Direct | |
| transaction | ADMA | Common Stock | Sale | $2,363,932 | -136,861 | -23% | $17.27 | 467,305 | 29 Aug 2024 | Direct | F1, F2 |
| holding | ADMA | Common Stock | 22,857 | 29 Aug 2024 | See Footnote | F3 | |||||
| holding | ADMA | Common Stock | 31,381 | 29 Aug 2024 | See Footnote | F4 | |||||
| holding | ADMA | Common Stock | 38,294 | 29 Aug 2024 | See Footnote | F5 | |||||
| holding | ADMA | Common Stock | 175 | 29 Aug 2024 | See Footnote | F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ADMA | Common Stock | Options Exercise | $435,031 | -118,861 | -100% | $3.66 | 0 | 29 Aug 2024 | Common Stock | 118,861 | $3.66 | Direct | F7 |
| transaction | ADMA | Common Stock | Options Exercise | $53,640 | -9,000 | -100% | $5.96 | 0 | 29 Aug 2024 | Common Stock | 9,000 | $5.96 | Direct | F8, F10 |
| transaction | ADMA | Common Stock | Options Exercise | $97,200 | -9,000 | -100% | $10.80 | 0 | 29 Aug 2024 | Common Stock | 9,000 | $10.80 | Direct | F9, F10 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $17.17 to $17.595. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F2 | Includes, as of the transaction date, (i) 12,020 restricted stock units granted on February 26, 2024, which will vest in full on February 26, 2025, subject to the Reporting Person's continued service as of the applicable vesting date; and (ii) 455,285 shares of common stock owned by the reporting person. |
| F3 | These shares are owned by Brookwood LLC ("Brookwood"). The reporting person is the managing member of Brookwood. |
| F4 | These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee. |
| F5 | These shares are owned by Genesis Foundation Inc. ("Genesis"). The reporting person is the President of Genesis. |
| F6 | These shares are owned by the reporting person's wife. |
| F7 | These options were granted on June 6, 2017 and vested in twenty-four equal monthly installments, becoming fully vested on June 6, 2019. |
| F8 | These options were granted on January 28, 2016 and vested in twenty-four equal monthly installments, becoming fully vested on January 28, 2018. |
| F9 | These options were granted on January 30, 2015 and vested in twenty-four equal monthly installments, becoming fully vested on January 30, 2017. |
| F10 | The Reporting Person is exercising these options due, in part, to their near-term expiration date. |
Exhibit 24 - Power of Attorney